Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Nichi-Iko Pharmaceutical Co., Ltd. NHKFF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • JP • USD

SharesGrow Score
25/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Nichi-Iko Pharmaceutical Co., Ltd. (NHKFF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.36. It has a SharesGrow Score of 24/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $179.1B, +2.8%/yr average growth. Net income is $105.0B (loss), growing at -872.9%/yr. Net profit margin is -58.6% (negative). Gross margin is 2.2% (-17.7 pp trend).

Balance sheet: total debt is $162.6B against $13.4B equity (Debt-to-Equity (D/E) ratio 12.14, leveraged). Current ratio is 1.05 (adequate). Debt-to-assets is 62.4%. Total assets: $260.6B.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 30/100 (Fail), Past 50/100 (Partial), Health 17/100 (Fail), Moat 20/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

NHKFF SharesGrow Score Overview

25/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 20/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — NHKFF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
30/100
NHKFF: +2.8%/yr revenue is, -872.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
NHKFF: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
17/100
Balance sheet NHKFF: Debt-to-Equity (D/E) ratio 12.14 (leveraged), Current ratio is 1.05 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
20/100
NHKFF: Gross margin is 2.2% (-17.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 20/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
NHKFF: Net profit margin is -58.6%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.358-0.359
Volume5K
Avg Volume (30D)1.85K
Beta (1Y)-0.66
Share Statistics
EPS (TTM)-104,984,000,000.00
Shares Outstanding$1.00
IPO Date2020-05-26
Employees2,656
CEOShingo Iwamoto
Financial Highlights & Ratios
Revenue (TTM)$179.06B
Gross Profit$3.97B
EBITDA$-94.06B
Net Income$-104.98B
Operating Income$-110.05B
Total Cash$15.73B
Total Debt$162.63B
Net Debt$147.33B
Total Assets$260.56B
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryJP
ExchangeOther OTC
CurrencyUSD
ISINJP3687200000

Price Chart

Track all markets on TradingView
NHKFF
Nichi-Iko Pharmaceutical Co., Ltd. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.36 52WK RANGE 0.36

People Also View

CRON
CRON
Cronos Group Inc.
$2.57
+0.78%
 TLRY
TLRY
Tilray Brands, Inc.
$6.91
+2.83%
 CGC
CGC
Canopy Growth Corporation
$1.09
+0.93%
 SNDL
SNDL
SNDL Inc.
$1.44
+5.11%
 GRUSF
GRUSF
Grown Rogue International Inc.
$0.32
+3.90%
 DBCCF
DBCCF
Decibel Cannabis Company Inc.
$0.09
+3.52%
 HEXO
HEXO
HEXO Corp.
$0.71
+2.45%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message